Table 2.
Plasma total fatty acid profiles by GC
| Experimental groups | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control eSS | ω6 | ω6 + NDGA | ω3 | ω3 + NDGA | Wistar | |||||||
| Fatty acids | ||||||||||||
| SFA | 23,56# | ±2,28 | 45,89#* | ±3,46 | 38,20#* | ±3,18 | 22,20#* | ±0,34 | 25,00#* | ±2,90 | 27,90* | ±2,53 |
| MUFAs | 27,60# | ±2,60 | 17,46#* | ±1,51 | 24,50#* | ±1,29 | 33,30* | ±0,25 | 45,40# | ±0,76 | 22,50* | ±1,36 |
| PUFAs ω6 | 38,20 | ±3,65 | 30,37#* | ±0,10 | 23,70#* | ±1,09 | 29,00* | ±0,04 | 12,00* | ±0,44 | 38,00* | ±3,18 |
| PUFAs ω3 | 4,00# | ±0,54 | 1,83 | ±0,01 | 6,20 | ±0,33 | 15,10 | ±0,16 | 19,30# | ±0,48 | 16,40* | ±0,36 |
| PUFAs Total | 42,20 | ±2,09 | 32,20# | ±0,05 | 29,10# | ±0,71 | 44,00 | ±0,10 | 31,10# | ±0,46 | 54,30* | ±1,77 |
| Ratio ω6/ω3 | 9,55# | 16,60# | 3,82#* | 1,92* | 0,62* | 2,32* | ||||||
Profiles was determined at 12TH month of age in experimental groups
#Indicate significant difference to Wistar, p ≤ 0.05. *Indicate significant difference to Control eSS, p ≤ 0.05